Personalis (NASDAQ:PSNL) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Personalis (NASDAQ:PSNL) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $11.00 price objective on the stock.

Separately, Needham & Company LLC reissued a “buy” rating and issued a $7.25 price objective on shares of Personalis in a report on Friday, December 20th.

Personalis Price Performance

PSNL opened at $5.60 on Wednesday. The firm has a fifty day moving average price of $4.69 and a 200 day moving average price of $4.32. Personalis has a 1 year low of $1.12 and a 1 year high of $7.20. The stock has a market cap of $395.63 million, a P/E ratio of -3.33 and a beta of 1.75.

Personalis (NASDAQ:PSNL) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.64) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.31). Personalis had a negative return on equity of 66.07% and a negative net margin of 104.52%. The firm had revenue of $25.71 million during the quarter, compared to analyst estimates of $20.67 million. During the same quarter last year, the company posted ($0.51) EPS. Equities analysts expect that Personalis will post -1.41 EPS for the current year.

Institutional Investors Weigh In On Personalis

Large investors have recently bought and sold shares of the company. Barclays PLC lifted its position in shares of Personalis by 45.4% in the third quarter. Barclays PLC now owns 65,468 shares of the company’s stock valued at $352,000 after acquiring an additional 20,444 shares in the last quarter. Geode Capital Management LLC raised its stake in Personalis by 20.0% in the 3rd quarter. Geode Capital Management LLC now owns 498,470 shares of the company’s stock valued at $2,683,000 after purchasing an additional 83,068 shares during the last quarter. Jane Street Group LLC raised its stake in Personalis by 154.3% in the 3rd quarter. Jane Street Group LLC now owns 164,281 shares of the company’s stock valued at $884,000 after purchasing an additional 99,671 shares during the last quarter. State Street Corp boosted its stake in Personalis by 34.5% during the 3rd quarter. State Street Corp now owns 175,142 shares of the company’s stock worth $942,000 after purchasing an additional 44,900 shares during the last quarter. Finally, Centiva Capital LP purchased a new stake in shares of Personalis during the third quarter worth $380,000. 61.91% of the stock is currently owned by hedge funds and other institutional investors.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.